US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
LTR Pharma Ltd (LTP) 銘柄情報

LTR Pharma Ltd (LTP)

0.57

0.03

(5.56%)

終了 7月3日 3:00PM

LTR Pharma Ltd (LTP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.57

( 5.56% )

買値

0.55

売値

0.575

出来高

154,312

0.5525 日の範囲 0.58

0.2825 52 週間の範囲 0.81

時価総額

前日終値

0.54

始値

0.555

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 477,142

発行済株式数

181,777,585

配当利回り

PER

-11.34

1 株当たり利益 (EPS)

-0.05

歳入

1.13M

純利益

-8.95M

LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for t... LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.ltrpharma.com

本社

Brisbane, Australia

設立

2026

LTR Pharma Ltd is listed in the sector of the オーストラリア証券取引所 with ticker LTP. The last closing price for LTR Pharma was AUD0.54. Over the last year, LTR Pharma shares have traded in a share price range of AUD 0.2825 to AUD 0.81.

LTR Pharma currently has 181,777,585 shares in issue. The market capitalisation of LTR Pharma is AUD103.61 million. LTR Pharma has a price to earnings ratio (PE ratio) of -11.34.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.03	-5	0.6	0.615	0.535	310267	0.56088366	DE
4	0.195	52	0.375	0.645	0.365	764947	0.52636973	DE
12	0.155	37.3493975904	0.415	0.645	0.35	500268	0.48032151	DE
26	-0.15	-20.8333333333	0.72	0.75	0.35	351568	0.49443125	DE
52	0.245	75.3846153846	0.325	0.81	0.2825	495644	0.51228171	DE
156	0.22	62.8571428571	0.35	2.15	0.235	598944	0.74706101	DE
260	0.22	62.8571428571	0.35	2.15	0.235	598944	0.74706101	DE

LTP - Frequently Asked Questions (FAQ)

What is the current LTR Pharma Ltd share price?

The current share price of LTR Pharma Ltd is AUD 0.57

How many LTR Pharma Ltd shares are in issue?

LTR Pharma Ltd has 181,777,585 shares in issue

What is the market cap of LTR Pharma Ltd?

The market capitalisation of LTR Pharma Ltd is AUD 103.61M

What is the 1 year trading range for LTR Pharma Ltd share price?

LTR Pharma Ltd has traded in the range of AUD 0.2825 to AUD 0.81 during the past year

What is the PE ratio of LTR Pharma Ltd?

The price to earnings ratio of LTR Pharma Ltd is -11.34

What is the cash to sales ratio of LTR Pharma Ltd?

The cash to sales ratio of LTR Pharma Ltd is 89.97

What is the registered address of LTR Pharma Ltd?

The registered address for LTR Pharma Ltd is 29/97 Creek Street, Brisbane, Queensland, 4000

What is the LTR Pharma Ltd website address?

The website address for LTR Pharma Ltd is www.ltrpharma.com

brazen22

brazen22 2分前

It’s easy to tell when a post landed. Otherwise, the incoming would be rebuttals, not sophomoric cheap shots

chazzy1

chazzy1 5分前

"Definitions and explanations generated entirely by AI are not copyrightable. Under U.S. copyright law, a work must have human authorship to receive protection. If an AI tool writes the definitions for you, they enter the public domain and anyone can copy them freely."
Thus I have no concerns

GoodGuyBill

GoodGuyBill 8分前

Sage007, you can call my prior post “cow dung” all you want, but facts don’t disappear because you refuse to read them. Here is a clean, structured list of NWBO’s accomplishments and MHRA accommodations over the last three years — each with what it is and why it matters-- that you ignore or believe

mauiguy2

mauiguy2 10分前

They're promising us less than they promised back in 2022.

Good Day LuLa!

Since you've been a solid backer of CYB for many years, I was a bit surprised to read your unhappiness regarding the welcomed shareholder letter.

I can give you 2 credible reasons

Idunno

Idunno 11分前

Or, is it something else?

CA Market News

CA Market News 12分前

Founders Metals Appoints Felicia de la Paz as Chief Financial OfficerJuly 3, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfil

I am done

I am done 12分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Carome

Carome 13分前

I fell for a complex options strategy from a YouTube guru. I didn’t understand pin risk or early assignment, and I lost £2,800 when a spread went wrong. Laura G. Prescott on Facebook simplified everything: she taught me covered calls on stocks I already owned. She personally helped me pick the first

I am done

I am done 13分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Idunno

Idunno 17分前

Are you really on a high school debate club?

PennyMillions852

PennyMillions852 18分前

All time garbage lows…..0002x.0003

JACKPOT

JACKPOT 19分前

No. I don't have anywhere near that amount

reg2015

reg2015 20分前

From David Innes. Slide show will be posted later today on our website. Can't wait. Is NWBO trading today on the Brit's Exchange?
I hope it is doing well. Peace Reg2015

brazen22

brazen22 21分前

Yes, if the control-arm mOS drops, the apparent difference versus DCVax-L increases.

But that is exactly why the method matters.

If I were trying to make the most credible case for a new drug, I would want to show benefit against a strong, comparable control group, not

cottonisking

cottonisking 23分前

5 sites
In the Lehman Brothers Holdings Inc. (LBHI) Chapter 11 bankruptcy, the legal relationship between "satisfied in full" and "paid in full" became a critical, multi-billion-dollar distinction heavily litigated in court.

FindLaw Caselaw
The core difference is that a

JoeForkeyBolo

JoeForkeyBolo 23分前

Sorry, Zero, I realized I already have your email. I will send the updated drawdown calculator that supports my current drawdown strategy. You can use it or continue with what you're already doing.

CA Market News

CA Market News 26分前

DOLLARAMA ANNONCE LE RENOUVELLEMENT DE SON OFFRE PUBLIQUE DE RACHAT DANS LE COURS NORMAL DES ACTIVITÉSJuly 3, 2026 7:00 AM
PR Newswire (Canada) class="legendSpanClass"MONTRÉAL, class="legendSpanClass"le 3 juill. 2026 /CNW/ - Dollarama in

CA Market News

CA Market News 26分前

Paramount Resources Announces Renewal of Normal Course Issuer Bid and July DividendJuly 3, 2026 7:00 AM
PR Newswire (Canada) class="legendSpanClass"CALGARY, AB, class="legendSpanClass"July 3, 2026 /CNW/ - Paramount Resources Ltd. ("Param

CA Market News

CA Market News 27分前

DOLLARAMA ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BIDJuly 3, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"MONTRÉAL, class="legendSpanClass"July 3, 2026 /PRNewswire/ - Dollarama Inc. (TSX: DOL) ("Dollarama" or the "Corporation")

deri21

deri21 28分前

$BSAI BluSky AI Inc. Announces Appointment of Mort Aaronson to Board of Directors
Experienced executive and strategic advisor, joins the Board as BluSky AI advances its modular AI infrastructure platform and long-term growth strategy.
https://www.globenewswire.com/news-release/2026/07

deri21

deri21 29分前

$BSAI BluSky AI Inc. Announces Appointment of Mort Aaronson to Board of Directors
Experienced executive and strategic advisor, joins the Board as BluSky AI advances its modular AI infrastructure platform and long-term growth strategy.
https://www.globenewswire.com/news-release/2026/07

OTC_Watchdog

OTC_Watchdog 29分前

Under OTC Markets' own standards, posting a report on your company website only works if OTC Markets verifies and links it on your profile.

Verification simply means OTC Markets acknowledges the filing exists and makes it accessible to investors — it is not a review of the accuracy o

Xtrackers Artificial Int...

RBC Quant US Equity Lead...

OncoSil Medical

Aguia Resources

Ci Global Energy Corpora...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。